Similar Articles
1351 Aberrant methylation of SPARC in human hepatocellular carcinoma and its clinical implication
1352 Factors associated with the overall survival of elderly patients with hepatocellular carcinoma
1353 Is hepatic arterial infusion chemotherapy effective treatment for advanced hepatocellular carcinoma resistant to transarterial chemoembolization?
1354 Hepatocellular carcinoma in Budd-Chiari syndrome: A single center experience with long-term follow-up in South Korea
1355 Pro-apoptotic effects of tectorigenin on human hepatocellular carcinoma HepG2 cells
1356 Glycer-AGEs-RAGE signaling enhances the angiogenic potential of hepatocellular carcinoma by upregulating VEGF expression
1357 Differential expression of Rab27A/B correlates with clinical outcome in hepatocellular carcinoma
1358 Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis
1359 Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma
1360 Targeted systemic therapies for hepatocellular carcinoma: Clinical perspectives, challenges and implications
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA